Delivery Order SPE2DB22D3016-SPE2DB25FABE8

Award Date 10/22/24
Potential Completion Date 11/13/24
Potential Value $24K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $8,528.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYVGART 400 MG/20 ML VIAL 20ML, a medical product, with a completion date of February 4, 2025. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,310.92 firm fixed-price delivery order is for the supply of VYVGART 400 MG/20 ML VIAL 20ML, a specialty pharmaceutical product, with a completion date of November 20, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award, valued at $17,056.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the DLA's Indefinite Delivery Contract (IDC) with AmerisourceBergen, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, with a ceiling value of $25,585.02, is for the delivery of VYVGART 400 MG/20 ML VIAL 20ML, a pharmaceutical product. This is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This federal contract award is a delivery order with a firm fixed price of $8,528.34 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYVGART 400 MG/20 ML VIAL 20ML, a pharmaceutical product, with a performance period ending on June 3, 2025. The contract is not set aside and represents an open competition award. AmerisourceBergen Drug Corp holds a significant...
This federal contract award, valued at $32,414.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the drug product VYVGART 400 MG/20 ML VIAL 20ML, with a performance period through December 6, 2024. The contract is a firm-fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award, valued at $25,151.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYVGART 400 MG/20 ML VIAL 20ML, a specialty medication, with a completion date of December 19, 2024. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of VYVGART 400 MG/20 ML VIAL 20ML. The contract is a firm fixed-price delivery order with a ceiling value of $25,585.02 and a period of performance ending on July 17, 2025. This award is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between Amerisourcebergen and...
This federal contract award, valued at $25,151.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYVGART 400 MG/20 ML VIAL 20ML, a specialty medication, with a completion date of December 24, 2024. Amerisourcebergen is the prime contractor for this award, which is not designated as a set-aside contract. The company also holds a $999,999,999 Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $34,113.36, is for the provision of VYVGART 400 MG/20 ML VIAL 20ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of February 12, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FABE8
    Delivery Order

This federal contract award, valued at $24,310.92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYVGART 400 MG/20 ML VIAL 20ML, a specialty pharmaceutical product, with a completion date of November 13, 2024.

The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 1/22/25, 12:53 AM